Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
and ultimately accelerate these activities to combat climate change. Our approach combines science and engineering, beginning with the study of fundamental microbial metabolic processes that can be
-
: In vitro and/or in vivo phage display; Cloning, engineering, expression, purification and characterization of VHHs. We invite applications from dynamic individuals with a strong drive for innovation
-
and ultimately accelerate these activities to combat climate change. Our approach combines science and engineering, beginning with the study of fundamental microbial metabolic processes that can be
-
14 Mar 2025 Job Information Organisation/Company Ghent University Research Field Biological sciences » Other Chemistry » Biochemistry Engineering » Biomedical engineering Engineering » Other Medical
-
) we are looking for a m/f/x Postdoctoral fellow YOUR JOB In the frame of a EU-Horizon project the UGent Department of Electromechanics, Systems and Metals Engineering in the Faculty of Engineering and
-
Engineering, or Electrical Engineering or Computer Science/engineering with a focus on network communications Good understanding of the 3GPP 5G radio access and core network protocols Proficiency in multiple
-
://www.imec-int.com/en/home ) (prof. C. Fleischmann). Profile You hold a PhD in computer science, physics, mathematics or engineering (or you will have obtained it by the time you start work). You have
-
. External and internal post-doc researchers must be eligible to submit an FWO post-doc. The list of eligibility criteria can be found here . Position This call invites innovative postdoctoral proposals
-
Overview The group of Specialized Metabolism , led by Prof. Alain Goossens at the VIB-UGent Center for Plant Systems Biology, and the metabolic engineering research group, led by Prof. Marjan De Mey
-
postdoctoral researcher - molecular mechanisms T-cell leukemia - Diagnostische Wetenschappen (28449)
expertise in genetic engineering, development of high throughput drug screening assays, generation of in vitro and in vivo cancer models to evaluate novel therapeutic strategies to combat aggressive subtypes